These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 19365057

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Elucidating the mechanism of action and potential interactions of MAO-B inhibitors.
    Bainbridge JL, Page RL, Ruscin JM.
    Neurol Clin; 2008 Aug; 26(3 Suppl):S85-96, vi. PubMed ID: 18774444
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Safety of rasagiline in elderly patients with Parkinson disease.
    Goetz CG, Schwid SR, Eberly SW, Oakes D, Shoulson I, Parkinson Study Group TEMPO and PRESTO Investigators.
    Neurology; 2006 May 09; 66(9):1427-9. PubMed ID: 16682679
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Comparative efficacy of selegiline versus rasagiline in the treatment of early Parkinson's disease.
    Jost WH, Friede M, Schnitker J.
    Eur Rev Med Pharmacol Sci; 2014 Nov 09; 18(22):3349. PubMed ID: 25491607
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Reexamination of the TEMPO Study.
    Shults CW.
    Arch Neurol; 2005 Aug 09; 62(8):1320; author reply 1321. PubMed ID: 16087778
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic/pharmacodynamic evaluation of rasagiline mesylate for Parkinson's disease.
    Müller T.
    Expert Opin Drug Metab Toxicol; 2014 Oct 09; 10(10):1423-32. PubMed ID: 25196265
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Selegiline, pregnancy, and Parkinson's disease.
    Kupsch A, Oertel WH.
    Mov Disord; 1998 Jan 09; 13(1):175-6. PubMed ID: 9452347
    [No Abstract] [Full Text] [Related]

  • 38. Rasagiline: a guide to its use in Parkinson's disease.
    Keating GM, Lyseng-Williamson KA, Hoy SM.
    CNS Drugs; 2012 Sep 01; 26(9):781-5. PubMed ID: 22834567
    [Abstract] [Full Text] [Related]

  • 39. Community and long-term care management of Parkinson's disease in the elderly: focus on monoamine oxidase type B inhibitors.
    Chen JJ, Fernandez HH.
    Drugs Aging; 2007 Sep 01; 24(8):663-80. PubMed ID: 17702535
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.